These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12712154)

  • 1. Biotech firms pin hopes on defence.
    Pearson H
    Nature; 2003 Apr; 422(6934):790. PubMed ID: 12712154
    [No Abstract]   [Full Text] [Related]  

  • 2. A defensive strategy.
    Lok C
    Nature; 2005 Oct; 437(7063):1392-3. PubMed ID: 16283702
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioterrorism--biotechnology to the rescue?
    Niiler E
    Nat Biotechnol; 2002 Jan; 20(1):21-5. PubMed ID: 11753354
    [No Abstract]   [Full Text] [Related]  

  • 4. US expands anti-bioterrorist measures.
    Fox JL
    Nat Biotechnol; 2001 Nov; 19(11):998-1000. PubMed ID: 11689831
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 6. US rejiggers Bioshield bill.
    Herrera S
    Nat Biotechnol; 2004 Jul; 22(7):792. PubMed ID: 15229526
    [No Abstract]   [Full Text] [Related]  

  • 7. US biodefense contracts continue to lure biotechs.
    Shaffer C
    Nat Biotechnol; 2010 Mar; 28(3):187-8. PubMed ID: 20212465
    [No Abstract]   [Full Text] [Related]  

  • 8. Materials exchange deal meager boost to India's biotech.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies for defense against biological attack.
    Casadevall A
    Nat Biotechnol; 2002 Feb; 20(2):114. PubMed ID: 11821846
    [No Abstract]   [Full Text] [Related]  

  • 10. War on terror: biochem. Tracking anthrax.
    Begley S
    Newsweek; 2001 Oct; 138(18):36-9. PubMed ID: 11699428
    [No Abstract]   [Full Text] [Related]  

  • 11. Learning from the 2001 anthrax attacks: immunological characteristics.
    Hadler JL
    J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
    [No Abstract]   [Full Text] [Related]  

  • 12. Biodefense: 10 years after. Reinventing Project BioShield.
    Cohen J
    Science; 2011 Sep; 333(6047):1216-8. PubMed ID: 21885752
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001.
    Bresnitz EA
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):389-91. PubMed ID: 15924332
    [No Abstract]   [Full Text] [Related]  

  • 14. Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats.
    Javitt GH
    J Health Care Law Policy; 2005; 8(1):38-70. PubMed ID: 16538801
    [No Abstract]   [Full Text] [Related]  

  • 15. Impending breakthroughs could turn more small biotech firms into major companies.
    Wagner M
    Mod Healthc; 1988 Mar; 18(10):41. PubMed ID: 10286307
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotechnology to fight bioterrorism. While the fight against terrorism is helping to revitalize the biotech market, academic scientists are starting to worry about limitations on research.
    Brower V
    EMBO Rep; 2003 Mar; 4(3):227-9. PubMed ID: 12634833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered chloroplasts as vaccine factories to combat bioterrorism.
    Streatfield SJ
    Trends Biotechnol; 2006 Aug; 24(8):339-42. PubMed ID: 16815579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US restrictions limit anthrax networking.
    Ozin A; Bade K; Kaufmann SH
    Nature; 2004 Oct; 431(7011):897. PubMed ID: 15496891
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH outlines goals to counter bioterror.
    Reid BB
    Nat Biotechnol; 2002 May; 20(5):414. PubMed ID: 11981537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.